US Stock MarketDetailed Quotes
EBS Emergent BioSolutions
- 9.400
- +0.520+5.86%
Close Nov 21 16:00 ET
- 9.300
- -0.100-1.06%
Post 18:09 ET
509.33MMarket Cap-2404P/E (TTM)
9.780High8.830Low1.28MVolume8.950Open8.880Pre Close11.95MTurnover2.59%Turnover RatioLossP/E (Static)54.18MShares15.10052wk High1.00P/B464.05MFloat Cap1.42052wk Low--Dividend TTM49.37MShs Float137.610Historical High--Div YieldTTM10.70%Amplitude1.420Historical Low9.349Avg Price1Lot Size
Emergent BioSolutions Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | 70.73%149.9M | -21.33%69.7M | -81.75%78.5M | -82.62%111.7M | -82.62%111.7M | -63.55%87.8M | -75.26%88.6M | -1.28%430.2M | 11.54%642.6M | 11.54%642.6M |
| -Cash and cash equivalents | 70.73%149.9M | -21.33%69.7M | -81.75%78.5M | -82.62%111.7M | -82.62%111.7M | -63.55%87.8M | -75.26%88.6M | -1.28%430.2M | 11.54%642.6M | 11.54%642.6M |
| Receivables | -43.97%121.3M | -32.33%196.3M | 49.78%233.5M | 19.97%191M | 19.97%191M | 13.17%216.5M | 65.77%290.1M | -14.25%155.9M | -42.92%159.2M | -42.92%159.2M |
| -Accounts receivable | -34.48%102.6M | -49.39%120.7M | 82.25%194.1M | 38.07%141.8M | 38.07%141.8M | 31.60%156.6M | 98.92%238.5M | -7.55%106.5M | -55.44%102.7M | -55.44%102.7M |
| -Other receivables | -68.52%19.2M | 59.27%82.5M | -16.47%41.6M | -10.14%51.4M | -10.14%51.4M | -15.63%61M | -5.99%51.8M | -25.23%49.8M | 10.85%57.2M | 10.85%57.2M |
| -Recievables adjustments allowances | 54.55%-500K | -3,350.00%-6.9M | -450.00%-2.2M | -214.29%-2.2M | -214.29%-2.2M | ---1.1M | ---200K | ---400K | 78.13%-700K | 78.13%-700K |
| Inventory | -8.87%322.7M | -10.39%317.5M | -9.38%333.4M | -6.22%328.9M | -6.22%328.9M | -35.18%354.1M | -16.73%354.3M | -8.19%367.9M | 1.80%350.7M | 1.80%350.7M |
| Restricted cash | --6.5M | --1.3M | --500K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other current assets | -2.24%61M | -19.46%36M | -12.47%36.5M | -17.27%47.9M | -17.27%47.9M | --62.4M | --44.7M | --41.7M | -17.52%57.9M | -17.52%57.9M |
| Total current assets | -8.24%661.4M | -15.84%654.5M | -44.13%682.4M | -43.86%679.5M | -43.86%679.5M | -35.56%720.8M | -28.27%777.7M | 11.00%1.22B | -4.69%1.21B | -4.69%1.21B |
| Non current assets | ||||||||||
| Net PPE | -29.67%278.1M | -22.58%306.2M | -47.07%379.4M | -53.18%382.8M | -53.18%382.8M | -50.99%395.4M | -50.46%395.5M | -11.23%716.8M | 2.19%817.6M | 2.19%817.6M |
| -Gross PPE | -15.62%671.9M | -10.17%706.9M | -26.56%802M | -33.89%794.2M | -33.89%794.2M | -32.11%796.3M | -31.93%786.9M | -3.98%1.09B | 7.34%1.2B | 7.34%1.2B |
| -Accumulated depreciation | 1.77%-393.8M | -2.38%-400.7M | -12.63%-422.6M | -7.19%-411.4M | -7.19%-411.4M | -9.48%-400.9M | -9.42%-391.4M | -13.77%-375.2M | -20.28%-383.8M | -20.28%-383.8M |
| Goodwill and other intangible assets | -11.15%517.8M | -34.14%534.1M | -33.45%550.4M | -40.17%566.6M | -40.17%566.6M | -38.50%582.8M | 1.19%811M | 1.42%827.1M | 14.17%947M | 14.17%947M |
| -Goodwill | ---- | ---- | ---- | --0 | --0 | --0 | -2.98%218.2M | -2.98%218.2M | -2.98%218.2M | -2.98%218.2M |
| -Other intangible assets | -11.15%517.8M | -9.90%534.1M | -9.61%550.4M | -22.26%566.6M | -22.26%566.6M | -19.36%582.8M | 2.81%592.8M | 3.10%608.9M | 20.54%728.8M | 20.54%728.8M |
| Other non current assets | -89.44%20.5M | -90.39%18.7M | 3.68%191.4M | 1.57%194.3M | 1.57%194.3M | 443.70%194.1M | 279.34%194.6M | 223.29%184.6M | 228.69%191.3M | 228.69%191.3M |
| Total non current assets | -30.36%816.4M | -38.69%859M | -35.13%1.12B | -41.53%1.14B | -41.53%1.14B | -34.51%1.17B | -15.15%1.4B | 2.88%1.73B | 15.88%1.96B | 15.88%1.96B |
| Total assets | -21.94%1.48B | -30.54%1.51B | -38.86%1.8B | -42.42%1.82B | -42.42%1.82B | -34.91%1.89B | -20.35%2.18B | 6.09%2.95B | 7.05%3.17B | 7.05%3.17B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | -27.15%82.1M | -11.45%95.9M | -19.32%100.2M | 8.41%112.2M | 8.41%112.2M | 8.57%112.7M | 1.98%108.3M | 15.75%124.2M | -19.71%103.5M | -19.71%103.5M |
| -accounts payable | -27.15%82.1M | -11.45%95.9M | -19.32%100.2M | 8.41%112.2M | 8.41%112.2M | 8.57%112.7M | 1.98%108.3M | 15.75%124.2M | -19.71%103.5M | -19.71%103.5M |
| Current accrued expenses | -5.29%16.1M | -44.87%17.2M | -32.86%14.3M | -46.70%18.6M | -46.70%18.6M | -52.65%17M | -22.58%31.2M | -27.30%21.3M | -32.50%34.9M | -32.50%34.9M |
| Current debt and capital lease obligation | -99.81%800K | -8.79%415.2M | -51.70%459.2M | -56.78%413.7M | -56.78%413.7M | 1,850.94%413.6M | 1,340.51%455.2M | 2,908.54%950.7M | 2,929.43%957.3M | 2,929.43%957.3M |
| -Current debt | -99.81%800K | -8.79%415.2M | -51.70%459.2M | -56.78%413.7M | -56.78%413.7M | 1,850.94%413.6M | 1,340.51%455.2M | 2,908.54%950.7M | 2,929.43%957.3M | 2,929.43%957.3M |
| Other current liabilities | 76.96%67.6M | -14.53%24.7M | -76.87%14.5M | -28.76%32.7M | -28.76%32.7M | 52.80%38.2M | 19.42%28.9M | 154.88%62.7M | -37.21%45.9M | -37.21%45.9M |
| Current liabilities | -65.38%229.9M | -10.60%619.7M | -48.16%630.2M | -47.00%651.3M | -47.00%651.3M | 147.39%664M | 150.52%693.2M | 387.84%1.22B | 228.58%1.23B | 228.58%1.23B |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | 47.66%661.8M | -0.22%447M | -0.22%446.7M | -0.45%446.5M | -0.45%446.5M | -56.57%448.2M | -43.55%448M | -44.14%447.7M | -44.59%448.5M | -44.59%448.5M |
| -Long term debt | 47.66%661.8M | -0.22%447M | -0.22%446.7M | -0.45%446.5M | -0.45%446.5M | -56.57%448.2M | -43.55%448M | -44.14%447.7M | -44.59%448.5M | -44.59%448.5M |
| Non current deferred liabilities | -20.04%41.9M | -39.90%34.8M | -41.71%34.8M | -20.94%47.2M | -20.94%47.2M | -53.95%52.4M | -38.01%57.9M | -40.71%59.7M | -36.01%59.7M | -36.01%59.7M |
| Other non current liabilities | 14.38%35.8M | 9.83%25.7M | 16.18%28M | -30.36%28.9M | -30.36%28.9M | -30.29%31.3M | -60.00%23.4M | -55.12%24.1M | -40.29%41.5M | -40.29%41.5M |
| Total non current liabilities | 39.03%739.5M | -4.12%507.5M | -4.14%509.5M | -4.93%522.6M | -4.93%522.6M | -55.33%531.9M | -44.02%529.3M | -44.40%531.5M | -43.46%549.7M | -43.46%549.7M |
| Total liabilities | -18.94%969.4M | -7.80%1.13B | -34.77%1.14B | -34.00%1.17B | -34.00%1.17B | -18.04%1.2B | 0.02%1.22B | 44.98%1.75B | 32.12%1.78B | 32.12%1.78B |
| Shareholders'equity | ||||||||||
| Share capital | 0.00%100K | 0.00%100K | 0.00%100K | 0.00%100K | 0.00%100K | 0.00%100K | 0.00%100K | 0.00%100K | 0.00%100K | 0.00%100K |
| -common stock | 0.00%100K | 0.00%100K | 0.00%100K | 0.00%100K | 0.00%100K | 0.00%100K | 0.00%100K | 0.00%100K | 0.00%100K | 0.00%100K |
| -Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Retained earnings | -753.79%-181.1M | -202.14%-295.9M | -102.32%-12.8M | -102.95%-21.8M | -102.95%-21.8M | -96.63%27.7M | -67.73%289.7M | -42.25%551M | -22.27%738.7M | -22.27%738.7M |
| Paid-in capital | 2.75%924.4M | 2.18%915.3M | 3.60%909.8M | 3.54%904.4M | 3.54%904.4M | 4.60%899.7M | 5.49%895.8M | 5.20%878.2M | 5.32%873.5M | 5.32%873.5M |
| Less: Treasury stock | 0.00%227.7M | 0.00%227.7M | 0.00%227.7M | 0.00%227.7M | 0.00%227.7M | 0.00%227.7M | 0.00%227.7M | 11.40%227.7M | 49.61%227.7M | 49.61%227.7M |
| Gains losses not affecting retained earnings | -180.77%-7.3M | -243.75%-5.5M | -650.00%-5.5M | -283.87%-5.7M | -283.87%-5.7M | 50.00%-2.6M | 73.77%-1.6M | 110.75%1M | 119.25%3.1M | 119.25%3.1M |
| Total stockholders'equity | -27.08%508.4M | -59.60%386.3M | -44.79%663.9M | -53.21%649.3M | -53.21%649.3M | -51.89%697.2M | -36.80%956.3M | -23.66%1.2B | -13.89%1.39B | -13.89%1.39B |
| Total equity | -27.08%508.4M | -59.60%386.3M | -44.79%663.9M | -53.21%649.3M | -53.21%649.3M | -51.89%697.2M | -36.80%956.3M | -23.66%1.2B | -13.89%1.39B | -13.89%1.39B |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
